| Bioactivity | Methylbiocin is an ATP competitive inhibitor for human CMG helicase with an IC50 of 59 µM. Methylbiocin exhibits potential in cancer research[1]. |
| Target | IC50: 59 µM (hCMG helicase) |
| CAS | 23370-12-9 |
| Formula | C36H40N2O11 |
| Molar Mass | 676.71 |
| Transport | Room temperature in continental US; may vary elsewhere. |
| Storage | Please store the product under the recommended conditions in the Certificate of Analysis. |
| Reference | [1]. Xiang S, et al., Identification of ATP-Competitive Human CMG Helicase Inhibitors for Cancer Intervention that Disrupt CMG-Replisome Function. Mol Cancer Ther. 2024 Jul 10. |